by EmpathiCSubstanceS | Nov 1, 2018 | Depression
Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA In an extraordinary step forward for the psychedelic drug research community, the US Food and Drug Administration (FDA) has just given psilocybin therapy for treatment-resistant...
by EmpathiCSubstanceS | Sep 1, 2018 | Anxiety, Cannabis Marijuana, Chronic Pain, Depression, Iboga, Kambo, MDMA Sassafras Molly, Neuropathy, OCD
Dennis van der Meijden isn’t aiming to see the face of God, feel one with the cosmos, grasp the hidden reality of time and space, or embark on a sacred journey. What the Dutch graphic designer, producer, and rapper (under the professional name Terilekst) wants—and...
by EmpathiCSubstanceS | Aug 9, 2018 | Depression
In the heart of the Amazon, women travel by boat to the wild town of Iquitos before driving deep into the jungle. Inside thatched huts, the symphony of frogs and insects builds to a crescendo and the jungle seems to come in through the netted walls, expanding like...
by EmpathiCSubstanceS | Jul 20, 2018 | Anxiety, Depression
Ayelet Waldman is a novelist, essayist, screenwriter, and activist, but to many she is best known as the author of a Times piece, from 2005, in which she stated that she was more in love with her husband than with her four children. (“Her eyes were close set, and she...
by EmpathiCSubstanceS | Jul 20, 2018 | Depression
The resumption of clinical research with psychedelics is producing preliminary evidence of benefit for a variety of conditions. These include depression, substance abuse and palliative care. Some research also indicates efficacy in attaining quasi-clinical goals such...
by EmpathiCSubstanceS | May 17, 2018 | Addiction, Depression
For years, the field of mental health has been largely barren of meaningful treatment advances. But now, scientists have new hope in the least likely of places: psychedelic drugs. Recent research suggests that certain psychedelic substances can help relieve anxiety,...
